Basic | |
---|---|
Market Cap | $3.64M |
Price | $1.33 |
52 Week Range | 0.61-3.45 |
Beta | 0.18 |
Margins | |
Gross Profit Margin | 0.00% |
Operating Profit Margin | 0.00% |
Net Profit Margin | 0.00% |
Valuation (TTM) | |
P/E Ratio | -0.59 |
Price to Sales Ratio | 0.00 |
Price to Book Ratio | 0.33 |
PEG Ratio | -0.22 |
Medical - Diagnostics & Research
Healthcare
85
2015-03-04T00:00:00.000Z
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
972 4 830 3401
Check-Cap Building, Isfiya, 30090, IL
0001610590